Published in Clin Endocrinol (Oxf) on September 02, 2008
Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid (2014) 2.77
2014 European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children. Eur Thyroid J (2014) 1.73
The role of clinical guidelines in patient care: thyroid hormone replacement in women of reproductive age. Thyroid (2010) 1.51
Hypopituitarism and successful pregnancy. Int J Clin Exp Med (2014) 0.81
Thyroid function: the complexity of maternal hypothyroidism during pregnancy. Nat Rev Endocrinol (2009) 0.78
Effectiveness of L-thyroxine treatment on TSH suppression during pregnancy in patients with a history of thyroid carcinoma after total thyroidectomy and radioiodine ablation. Radiol Oncol (2012) 0.77
Thyroid gland: Early adjustment of levothyroxine treatment in pregnancy. Nat Rev Endocrinol (2010) 0.75
Thyroid hormone replacement in women of reproductive age: is surgeon knowledge related to operative volume? Thyroid (2010) 0.75
Effects of increasing levothyroxine on pregnancy outcomes in women with uncontrolled hypothyroidism. Clin Endocrinol (Oxf) (2016) 0.75
Laparoscopic vs vaginal hysterectomy for benign pathology. Am J Obstet Gynecol (2009) 2.20
Cortisol secretion in patients with type 2 diabetes: relationship with chronic complications. Diabetes Care (2007) 1.97
Identification of new variants of human BMP15 gene in a large cohort of women with premature ovarian failure. J Clin Endocrinol Metab (2006) 1.81
BRAF mutations in an Italian cohort of thyroid cancers. Clin Endocrinol (Oxf) (2004) 1.75
Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am J Hum Genet (2004) 1.72
Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism. J Clin Endocrinol Metab (2010) 1.69
Hypogonadotropic hypogonadism as a presenting feature of late-onset X-linked adrenal hypoplasia congenita. J Clin Endocrinol Metab (2002) 1.68
Growth hormone-releasing hormone resistance in pseudohypoparathyroidism type ia: new evidence for imprinting of the Gs alpha gene. J Clin Endocrinol Metab (2003) 1.67
The gsalpha gene: predominant maternal origin of transcription in human thyroid gland and gonads. J Clin Endocrinol Metab (2002) 1.67
Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of albright hereditary osteodystrophy and molecular analysis in 40 patients. J Clin Endocrinol Metab (2010) 1.53
Circulating levels of ghrelin in human fetuses. Eur J Endocrinol (2003) 1.52
Ghrelin and adiponectin in patients with Cushing's disease before and after successful transsphenoidal surgery. Clin Endocrinol (Oxf) (2005) 1.51
Risk of new vertebral fractures in patients with adrenal incidentaloma with and without subclinical hypercortisolism: a multicenter longitudinal study. J Bone Miner Res (2011) 1.50
A novel tyrosine-kinase selective inhibitor, sunitinib, induces transient hypothyroidism by blocking iodine uptake. J Clin Endocrinol Metab (2007) 1.47
A 7-year experience with low blood TSH cutoff levels for neonatal screening reveals an unsuspected frequency of congenital hypothyroidism (CH). Clin Endocrinol (Oxf) (2009) 1.45
Accuracy of several parameters of hypothalamic-pituitary-adrenal axis activity in predicting before surgery the metabolic effects of the removal of an adrenal incidentaloma. Eur J Endocrinol (2010) 1.44
Influence of the d3GH receptor polymorphism on the metabolic and biochemical phenotype of GH-deficient adults at baseline and during short- and long-term recombinant human GH replacement therapy. Eur J Endocrinol (2010) 1.42
The therapeutic outcome to intravenous steroid therapy for active Graves' orbitopathy is influenced by the time of response but not polymorphisms of the glucocorticoid receptor. Eur J Endocrinol (2013) 1.42
Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study. Eur J Endocrinol (2007) 1.35
Loss-of-function mutations in IGSF1 cause an X-linked syndrome of central hypothyroidism and testicular enlargement. Nat Genet (2012) 1.34
Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans. J Clin Invest (2010) 1.33
Intracellular entrapment of wild-type TSH receptor by oligomerization with mutants linked to dominant TSH resistance. Hum Mol Genet (2005) 1.30
Fetal microchimerism as an explanation of disease. Nat Rev Endocrinol (2010) 1.29
Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin Endocrinol (Oxf) (2007) 1.26
An alternate translation initiation site circumvents an amino-terminal DAX1 nonsense mutation leading to a mild form of X-linked adrenal hypoplasia congenita. J Clin Endocrinol Metab (2003) 1.23
Long-term follow-up study of patients with adrenal incidentalomas. Eur J Endocrinol (2002) 1.17
The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies. Clin Endocrinol (Oxf) (2010) 1.17
Germline mutations of TSH receptor gene as cause of nonautoimmune subclinical hypothyroidism. J Clin Endocrinol Metab (2002) 1.16
Fetal cell microchimerism in papillary thyroid cancer: studies in peripheral blood and tissues. Int J Cancer (2010) 1.14
Biallelic expression of the Gsalpha gene in human bone and adipose tissue. J Clin Endocrinol Metab (2004) 1.14
Functional characterization of wild-type and mutated pendrin (SLC26A4), the anion transporter involved in Pendred syndrome. J Mol Endocrinol (2009) 1.14
Placental-fetal interrelationship in IUGR fetuses--a review. Placenta (2002) 1.13
Maternal and fetal amino acid concentrations in normal pregnancies and in pregnancies with gestational diabetes mellitus. Am J Obstet Gynecol (2005) 1.12
Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer. J Clin Endocrinol Metab (2011) 1.11
Pregnancy outcome after cabergoline treatment in early weeks of gestation. Reprod Toxicol (2002) 1.09
Stimulatory effects of ghrelin on circulating somatostatin and pancreatic polypeptide levels. J Clin Endocrinol Metab (2003) 1.09
Differential diagnosis between Pendred and pseudo-Pendred syndromes: clinical, radiologic, and molecular studies. Pediatr Res (2002) 1.06
Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves' orbitopathy: a randomized controlled study. J Clin Endocrinol Metab (2014) 1.06
A family with complete resistance to thyrotropin-releasing hormone. N Engl J Med (2009) 1.05
Fetal and maternal non-glucose carbohydrates and polyols concentrations in normal human pregnancies at term. Pediatr Res (2005) 1.03
Different responses to chronic somatostatin analogues in patients with central hyperthyroidism. Clin Endocrinol (Oxf) (2005) 1.02
Genetic analysis and evaluation of resistance to thyrotropin and growth hormone-releasing hormone in pseudohypoparathyroidism type Ib. J Clin Endocrinol Metab (2007) 1.01
Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors. Eur J Endocrinol (2006) 1.01
BMP15 mutations associated with primary ovarian insufficiency cause a defective production of bioactive protein. Hum Mutat (2009) 1.00
Frequent association between MEN 2A and cutaneous lichen amyloidosis. Clin Endocrinol (Oxf) (2003) 1.00
Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression. Eur J Endocrinol (2006) 1.00
Proliferation of transformed somatotroph cells related to low or absent expression of protein kinase a regulatory subunit 1A protein. Cancer Res (2004) 0.99
Rituximab treatment in a patient with severe thyroid-associated ophthalmopathy: effects on orbital lymphocytic infiltrates. Clin Immunol (2009) 0.99
Bone mineral density, prevalence of vertebral fractures, and bone quality in patients with adrenal incidentalomas with and without subclinical hypercortisolism: an Italian multicenter study. J Clin Endocrinol Metab (2009) 0.99
Female sexual dysfunction and diabetes: a systematic review and meta-analysis. J Sex Med (2013) 0.99
Fetal cell microchimerism in papillary thyroid cancer: a possible role in tumor damage and tissue repair. Cancer Res (2008) 0.98
Clinical and molecular features of differentiated thyroid cancer diagnosed during pregnancy. Eur J Endocrinol (2009) 0.98
Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity. Clin Cancer Res (2007) 0.98
Cell-specific regulation of PTX3 by glucocorticoid hormones in hematopoietic and nonhematopoietic cells. J Biol Chem (2008) 0.97
Two novel nonsense mutations in GALNT3 gene are responsible for familial tumoral calcinosis. J Hum Genet (2007) 0.97
Classification and proposed nomenclature for inherited defects of thyroid hormone action, cell transport, and metabolism. J Clin Endocrinol Metab (2014) 0.97
Bone involvement in aldosteronism. J Bone Miner Res (2012) 0.95
Histopathological and molecular studies in patients with goiter and hypercalcitoninemia: reactive or neoplastic C-cell hyperplasia? Endocr Relat Cancer (2007) 0.95
High rate of endometriosis recurrence in young women. J Pediatr Adolesc Gynecol (2011) 0.94
Long-term follow-up in adrenal incidentalomas: an Italian multicenter study. J Clin Endocrinol Metab (2014) 0.94
Fetal cell microchimerism in human cancers. Cancer Lett (2009) 0.94
Long-term evaluation of postoperative acromegalic patients in remission with previous and newly proposed criteria. J Clin Endocrinol Metab (2004) 0.93
TBG deficiency: description of two novel mutations associated with complete TBG deficiency and review of the literature. J Mol Med (Berl) (2006) 0.92
Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients. Eur J Endocrinol (2012) 0.92
The limited role of midnight salivary cortisol levels in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentaloma. Eur J Endocrinol (2008) 0.92
Cutaneous lichen amyloidosis in multiple endocrine neoplasia type 2A. Thyroid (2002) 0.92
Selective modulation of protein kinase A I and II reveals distinct roles in thyroid cell gene expression and growth. Mol Endocrinol (2006) 0.92
Central hypothyroidism. Pituitary (2008) 0.92
Autosomal dominant pseudohypoparathyroidism type Ib: a novel inherited deletion ablating STX16 causes loss of imprinting at the A/B DMR. J Clin Endocrinol Metab (2014) 0.92
Effects of modified sham feeding on ghrelin levels in healthy human subjects. J Clin Endocrinol Metab (2004) 0.92
Protein kinase A regulatory subunits in human adipose tissue: decreased R2B expression and activity in adipocytes from obese subjects. Diabetes (2008) 0.91
DAX1 and X-linked adrenal hypoplasia congenita: clinical and molecular analysis in five patients. Eur J Endocrinol (2006) 0.91
Parental origin of Gsalpha mutations in the McCune-Albright syndrome and in isolated endocrine tumors. J Clin Endocrinol Metab (2004) 0.91
Bone quality, as measured by trabecular bone score in patients with adrenal incidentalomas with and without subclinical hypercortisolism. J Bone Miner Res (2012) 0.89
Fast fluorometric method for measuring pendrin (SLC26A4) Cl-/I- transport activity. Cell Physiol Biochem (2006) 0.89
A novel albumin gene mutation (R222I) in familial dysalbuminemic hyperthyroxinemia. J Clin Endocrinol Metab (2014) 0.89
Post-surgical hypocortisolism after removal of an adrenal incidentaloma: is it predictable by an accurate endocrinological work-up before surgery? Eur J Endocrinol (2009) 0.88
Effects of chronic administration of PPAR-gamma ligand rosiglitazone in Cushing's disease. Eur J Endocrinol (2004) 0.88
Incidence of second neoplasm in childhood cancer survivors treated with GH: an analysis of GeNeSIS and HypoCCS. Eur J Endocrinol (2013) 0.88
Gamma-knife radiosurgery in acromegaly: a 4-year follow-up study. J Clin Endocrinol Metab (2003) 0.88
Functional characterization of wild-type and a mutated form of SLC26A4 identified in a patient with Pendred syndrome. Cell Physiol Biochem (2006) 0.88
Personality features of obese women in relation to binge eating and night eating. Psychiatry Res (2012) 0.87
Small dose of rituximab for graves orbitopathy: new insights into the mechanism of action. Arch Ophthalmol (2012) 0.87
Recombinant human GH replacement therapy in children with pseudohypoparathyroidism type Ia: first study on the effect on growth. J Clin Endocrinol Metab (2010) 0.87
Prevalence of subclinical contributors to low bone mineral density and/or fragility fracture. Eur J Endocrinol (2013) 0.87
Quantitative analysis of methylation defects and correlation with clinical characteristics in patients with pseudohypoparathyroidism type I and GNAS epigenetic alterations. J Clin Endocrinol Metab (2013) 0.86
The dopamine-somatostatin chimeric compound BIM-23A760 exerts antiproliferative and cytotoxic effects in human non-functioning pituitary tumors by activating ERK1/2 and p38 pathways. Cancer Lett (2009) 0.86
Abnormal spiral artery remodelling in the decidual segment during pregnancy: from histology to clinical correlation. J Clin Pathol (2011) 0.86
The clinical spectrum of multiple endocrine neoplasia type 2a caused by the rare intracellular RET mutation S891A. J Clin Endocrinol Metab (2010) 0.86
The third intracellular loop of the human somatostatin receptor 5 is crucial for arrestin binding and receptor internalization after somatostatin stimulation. Mol Endocrinol (2007) 0.86
Treatment of pretibial myxedema with dexamethazone injected subcutaneously by mesotherapy needles. Thyroid (2013) 0.86
Onset of autoimmune hepatitis during intravenous steroid therapy for thyroid-associated ophthalmopathy in a patient with Hashimoto's thyroiditis: case report. Thyroid (2004) 0.86
Microchimerism and endocrine disorders. J Clin Endocrinol Metab (2012) 0.86
Evolution of an aggressive prolactinoma into a growth hormone secreting pituitary tumor coincident with GNAS gene mutation. J Clin Endocrinol Metab (2009) 0.86
Fibrosis is associated with adiponectin resistance in chronic hepatitis C virus infection. Eur J Clin Invest (2011) 0.86